Jiafu Ji Selected Research

Drug Therapy (Chemotherapy)

4/2022	Current status and perspectives of conversion therapy for advanced gastric cancer.
1/2022	Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis.
12/2021	Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy.
3/2021	The T-Cell-Inflammation Status Can Predict Outcomes of Adjuvant Chemotherapy in Patients with Gastric Cancer.
1/2021	The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
1/2021	EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance.
1/2021	Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A "Less Is More" Question When ypN0 Is Achieved.
1/2021	Correlative Analysis Between Adverse Events of Preoperative Chemotherapy and Postoperative Complications of Gastric Cancer.
1/2021	Clinicopathological Characteristics and Response to Chemotherapy in Treatment-Naive Epstein-Barr Virus Associated Gastric Cancer: A Retrospective Study.
1/2021	5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiafu Ji Research Topics

Disease

126	Stomach Neoplasms (Stomach Cancer) 06/2022 - 12/2002
109	Neoplasms (Cancer) 10/2022 - 02/2004
27	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2002
17	Carcinoma (Carcinomatosis) 01/2021 - 09/2002
13	Adenocarcinoma 12/2021 - 12/2002
12	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 03/2006
9	Carcinogenesis 01/2021 - 01/2012
6	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2014
4	Pancreatic Neoplasms (Pancreatic Cancer) 06/2021 - 03/2016
4	Colonic Neoplasms (Colon Cancer) 01/2016 - 03/2006
4	Lymphatic Metastasis 05/2014 - 03/2006
3	Microsatellite Instability 10/2022 - 03/2016
3	Inflammation (Inflammations) 03/2021 - 03/2015
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 06/2017
3	Infections 12/2020 - 11/2017
3	Rectal Neoplasms (Rectal Cancer) 01/2020 - 04/2017
3	Anastomotic Leak 08/2016 - 01/2016
2	COVID-19 02/2022 - 04/2021
2	Lung Neoplasms (Lung Cancer) 09/2021 - 08/2021
2	Disease Progression 06/2021 - 10/2016
2	Margins of Excision 04/2021 - 06/2012
2	Neuroblastoma 01/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2018 - 10/2015
2	Vomiting 04/2016 - 09/2015
2	Nausea 04/2016 - 09/2015
2	Gastritis 06/2012 - 01/2012
1	Diarrhea 02/2022
1	Flatulence 02/2022
1	Insulin Resistance 01/2022
1	Residual Neoplasm 01/2022
1	Necrosis 01/2022

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 06/2022 - 02/2004
21	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2007
12	Messenger RNA (mRNA)IBA 01/2022 - 01/2003
10	Pharmaceutical PreparationsIBA 04/2022 - 02/2016
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2012
9	Biological ProductsIBA 01/2021 - 02/2013
7	Fluorouracil (Carac)FDA LinkGeneric 12/2021 - 01/2014
7	CateninsIBA 12/2021 - 01/2017
6	RNA (Ribonucleic Acid)IBA 12/2021 - 06/2017
6	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2012
5	Phosphotransferases (Kinase)IBA 06/2021 - 02/2013
4	Long Noncoding RNAIBA 01/2022 - 01/2019
4	Trastuzumab (Herceptin)FDA Link 08/2021 - 01/2013
4	Indicators and Reagents (Reagents)IBA 01/2019 - 02/2013
4	yangzheng xiaojiIBA 09/2015 - 07/2012
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 09/2018
3	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2012
3	LigandsIBA 01/2021 - 02/2014
3	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 01/2012
3	Calcibiotic Root Canal SealerIBA 01/2018 - 03/2006
3	hydrogen sulfite (bisulfite)IBA 09/2014 - 01/2012
3	Complementary DNA (cDNA)IBA 08/2003 - 09/2002
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2017
2	InterleukinsIBA 01/2022 - 03/2016
2	PlatinumIBA 12/2021 - 08/2016
2	Tumor Biomarkers (Tumor Markers)IBA 07/2021 - 01/2014
2	Small Interfering RNA (siRNA)IBA 04/2021 - 05/2013
2	ProteomeIBA 01/2021 - 01/2018
2	tdTomatoIBA 01/2020 - 01/2020
2	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 01/2020
2	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2019
2	MicellesIBA 01/2019 - 01/2018
2	Cadherins (E-Cadherin)IBA 01/2019 - 09/2008
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 02/2013
2	Leucine (L-Leucine)FDA Link 01/2019 - 02/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2018
2	AntigensIBA 10/2017 - 05/2009
2	ParaffinIBA 10/2017 - 02/2004
2	Formaldehyde (Formol)FDA Link 10/2017 - 02/2004
2	Cetuximab (Erbitux)FDA Link 10/2017 - 10/2013
2	Cysteine (L-Cysteine)FDA Link 06/2017 - 11/2016
2	Adenylate KinaseIBA 01/2017 - 01/2017
2	CytokinesIBA 01/2016 - 10/2014
2	TOR Serine-Threonine KinasesIBA 11/2014 - 02/2013
2	MTOR InhibitorsIBA 11/2014 - 02/2013
1	Therapeutic UsesIBA 02/2022
1	Insulin (Novolin)FDA Link 01/2022
1	maltodextrinIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022

Therapy/Procedure

47	Gastrectomy 12/2021 - 01/2012
34	Therapeutics 04/2022 - 04/2010
29	Neoadjuvant Therapy 01/2022 - 08/2012
28	Drug Therapy (Chemotherapy) 04/2022 - 07/2012
12	Adjuvant Chemotherapy 12/2021 - 03/2008
11	Lymph Node Excision (Lymph Node Dissection) 12/2021 - 04/2014
6	Immunotherapy 10/2022 - 01/2020
4	Precision Medicine 04/2022 - 01/2016
4	Length of Stay 02/2022 - 02/2009
2	Proctectomy 01/2022 - 01/2020
2	Chemoradiotherapy 01/2020 - 09/2018
2	Hyperthermic Intraperitoneal Chemotherapy 01/2016 - 06/2015
2	Cytoreduction Surgical Procedures 01/2016 - 06/2015
1	Moxibustion 02/2022
1	Oral Administration 01/2022